VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

Completed · Phase 3 · Has a placebo group

Conditions studied: Insomnia

In brief

The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.

Key facts

Study ID
NCT00291187
Run by
Vanda Pharmaceuticals
People needed
411
Starts
2006-02-01
Expected to finish
2006-08-01
Last updated by the study team
2014-10-15

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.